MetALD: Terminology, Implications, and Therapeutic Considerations
Zeitschrift für Gastroenterologie · 01.09.2026 · 64 (09) · 1281-1290
DOI: 10.1055/a-2922-7499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2026. Verfasst von Eda Kaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ruhr University Bochum, Department of Medicine, Knappschaft Kliniken University Hospital Bochum, NRW, Germany, Bochum. Hauptthemen laut MEDLINE: Terminology as Topic, Fatty Liver, Alcohol Drinking. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
With the introduction of steatotic liver disease (SLD) as an umbrella term and metabolic dysfunction-associated steatotic liver disease (MASLD) as one of its major subcategories, a new diagnostic category was proposed to better reflect the coexistence of metabolic dysfunction and alcohol consumption: MetALD. MetALD identifies individuals with hepatic steatosis and cardiometabolic risk factors whose alcohol intake exceeds MASLD thresholds but remains below the levels typical of alcohol-related liver disease. The prevalence of MetALD in the general population is approximately 4%. Evidence suggests that MetALD is associated with more severe liver-related outcomes and higher all-cause mortality compared to MASLD, although findings are not entirely consistent. Despite these risks, MetALD remains underdiagnosed because alcohol consumption is often self-reported and underestimated due to recall bias, social desirability bias, or stigma. Consequently, managing MetALD requires a multidisciplinary approach addressing both cardiometabolic comorbidities and alcohol-related behavioral factors. MetALD should be viewed not only as a medical condition but also as a disorder with significant behavioral and social dimensions that influence diagnosis, treatment adherence, and long-term outcomes. This review discusses the clinical implications and therapeutic considerations specific to this newly introduced terminology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ruhr University Bochum, Department of Medicine, Knappschaft Kliniken University Hospital Bochum, NRW, Germany, Bochum.
ORCID-Profile: Ali Canbay
Zitieren
APA
Kaya, E., Nashtar, M. A., Kreimeyer, H., & Canbay, A. (2026). MetALD: Terminology, Implications, and Therapeutic Considerations. Zeitschrift für Gastroenterologie, 64(09), 1281-1290. https://doi.org/10.1055/a-2922-7499
Vancouver
Kaya E, Nashtar MA, Kreimeyer H, Canbay A. MetALD: Terminology, Implications, and Therapeutic Considerations. Zeitschrift für Gastroenterologie. 2026;64(09):1281-1290. doi:10.1055/a-2922-7499
BibTeX
@article{Kaya2026,
author = {Kaya, Eda and Nashtar, Mohamad Amer and Kreimeyer, Henriette and Canbay, Ali},
title = {MetALD: Terminology, Implications, and Therapeutic Considerations},
journal = {Zeitschrift für Gastroenterologie},
year = {2026},
volume = {64},
number = {09},
pages = {1281--1290},
doi = {10.1055/a-2922-7499}
}
EUVIMED